Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 24, 2025
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has notified exchanges about its 41st AGM, to be held on July 24, 2025 at 11:00 AM IST via video conferencing. The agenda includes adopting the FY25 audited financial statements and declaring a final dividend of ₹8 per equity share (face value ₹1), with payment due on or before July 30, 2025. A key special business item is the re-appointment of G V Prasad as Co-Chairman and Managing Director for another 5-year term (January 30, 2026 to January 29, 2031), with his monthly salary rising from ₹12 lakh to ₹14.4 lakh and HRA from ₹6 lakh to ₹7.2 lakh, along with up to 0.75% of net profits as commission. The notice also seeks ratification of ₹9 lakh remuneration for Cost Auditors Sagar & Associates for FY26, and approval to appoint Makarand M. Joshi & Co. as Secretarial Auditors for a 5-year term starting April 1, 2025. E-voting runs from July 20 to July 23, with July 17 as the cut-off date.
Shareholders stand to receive an ₹8 per share dividend if approved at the AGM, with the record date set as July 10, 2025. The proposed leadership continuity with a revised executive pay package (~85% variable and performance-linked) is broadly in line with peer benchmarks and unlikely to be controversial, making this a routine procedural filing with no major price-moving signal.